Edition:
India

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

126.60USD
30 Aug 2016
Change (% chg)

$-0.04 (-0.03%)
Prev Close
$126.64
Open
$126.26
Day's High
$127.39
Day's Low
$125.76
Volume
27,034
Avg. Vol
38,745
52-wk High
$157.84
52-wk Low
$122.99

TARO.N

Chart for TARO.N

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.83
Market Cap(Mil.): $5,415.88
Shares Outstanding(Mil.): 42.77
Dividend: --
Yield (%): --

Financials

  TARO.N Industry Sector
P/E (TTM): 10.02 36.89 36.63
EPS (TTM): 12.63 -- --
ROI: 32.25 14.54 14.02
ROE: 32.38 15.38 14.98

BRIEF-Taro posts qtrly earnings per share $2.59

* Quarterly earnings per share $2.59 Source text for Eikon: Further company coverage:

11 Aug 2016

BRIEF-Taro Pharma CEO Kal Sundaram to return to Sun Pharma headquarters by the end of 2016

* Taro ceo Kal Sundaram to return to Sun Pharma headquarters by the end of 2016

07 Jul 2016

BRIEF-Amarin appoints Michael Kalb chief financial officer

* Kalb joins Amarin from Taro Pharmaceutical Industries Ltd Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

30 Jun 2016

BRIEF-Taro pharmaceutical industries Q4 shr $2.68

* Qtrly net sales of $265.1 million, increased $20.9 million, or 8.6%, on relatively flat volumes

27 May 2016

Earnings vs. Estimates